Hemostasis Today

July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Manal Rayyan: Efanesoctocog Alfa Shows Excellent Real-World Performance
Jul 28, 2026, 13:46

Manal Rayyan: Efanesoctocog Alfa Shows Excellent Real-World Performance

Manal Rayyan, Adjunct Assistant Professor at United Arab Emirates University, Senior Clinical Pharmacist at SEHA Tawam Hospital, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood, adding:

“I’m pleased to share our latest publication:

‘Real-world treatment patterns and outcomes of switching to efanesoctocog alfa in children with haemophilia A: A single-centre experience from the UAE.’

Conducted at Tawam Hospital, this study shows excellent real-world outcomes after switching to once-weekly efanesoctocog alfa prophylaxis, with all patients achieving zero annualized bleeding rate (ABR) and demonstrating a strong safety profile.

I’m grateful to my co-authors and colleagues for their collaboration and commitment to improving care for children with bleeding disorders.

Congratulations to the entire team!”

Title: Real-world treatment patterns and outcomes of switching to efanesoctocog alfa in children with severe and moderate haemophilia a: A single-centre experience from the United Arab Emirates

Authors: Muhammad Faisal Khanani, Najam Awan, Haydar Alrufaey, Manal Ryan

Manal Rayyan: Efanesoctocog Alfa Shows Excellent Real-World Performance
Stay updated on all scientific advances with Hemostasis Today.